Security key
75886F107
REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN)
CUSIP: 75886F107
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 103,945,862
- Total 13F shares
- 89,193,388
- Share change
- +2,084,442
- Total reported value
- $68,856,656,317
- Put/Call ratio
- 57%
- Price per share
- $771.87
- Number of holders
- 1,376
- Value change
- +$1,925,429,106
- Number of buys
- 687
- Number of sells
- 565
Report period
Q4 2025
Institutions
1,376
Top holders
10
REGN full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
REGENERON PHARMACEUTICALS, INC. SEC filings
REGENERON PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75886F107
Recent filing periods:
Top shareholders of REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO |
13D/G
13F
|
Company |
4.4%
|
4,742,611
|
$2,729,989,170 | -$462,704,633 | 30 May 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
3.2%
|
3,359,563
|
$1,880,548,739 | -$2,703,197,470 | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.7%
|
9,048,269
|
$5,087,570,211 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
8.5%
|
8,837,174
|
$4,968,878,140 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.5%
|
4,691,223
|
$2,637,733,956 | — | 30 Sep 2025 | |
| DODGE & COX |
13F
|
Company |
4.4%
|
4,550,845
|
$2,558,803,618 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
2,535,898
|
$1,419,627,369 | — | 30 Sep 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.4%
|
2,453,143
|
$1,379,328,713 | — | 30 Sep 2025 | |
| Capital World Investors |
13F
|
Company |
1.9%
|
1,998,366
|
$1,123,608,855 | — | 30 Sep 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.9%
|
1,979,453
|
$1,112,987,056 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.4%
|
1,484,473
|
$834,674,573 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
1,450,972
|
$815,840,196 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.1%
|
1,175,277
|
$660,822,999 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
1,153,933
|
$648,821,756 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.95%
|
984,792
|
$553,718,997 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.92%
|
952,839
|
$535,752,949 | — | 30 Sep 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.89%
|
926,200
|
$520,774,474 | — | 30 Sep 2025 | |
| Capital International Investors |
13F
|
Company |
0.84%
|
876,564
|
$492,851,584 | — | 30 Sep 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.83%
|
861,593
|
$484,447,896 | — | 30 Sep 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.77%
|
804,910
|
$452,578,000 | — | 30 Sep 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.74%
|
770,359
|
$433,149,757 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.73%
|
755,565
|
$424,831,533 | — | 30 Sep 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.72%
|
744,173
|
$418,426,152 | — | 30 Sep 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.69%
|
721,354
|
$405,595,821 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.67%
|
696,681
|
$391,722,827 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.65%
|
671,630
|
$377,637,607 | — | 30 Sep 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.64%
|
660,595
|
$371,435,512 | — | 30 Sep 2025 | |
| Amundi |
13F
|
Individual |
0.6%
|
621,741
|
$364,016,919 | — | 30 Sep 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.56%
|
584,505
|
$328,594,000 | — | 30 Sep 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.53%
|
548,734
|
$308,536,666 | — | 30 Sep 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.5%
|
523,883
|
$294,563,694 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.48%
|
499,096
|
$280,615,836 | — | 30 Sep 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.46%
|
477,810
|
$268,658,229 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.46%
|
477,652
|
$268,569,390 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.45%
|
469,903
|
$264,212,360 | — | 30 Sep 2025 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Company |
0.44%
|
462,502
|
$260,051,010 | — | 30 Sep 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.43%
|
445,325
|
$250,392,888 | — | 30 Sep 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.4%
|
415,714
|
$233,743,278 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.37%
|
386,884
|
$217,533,266 | — | 30 Sep 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.37%
|
381,015
|
$214,232,754 | — | 30 Sep 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.36%
|
374,264
|
$210,437,419 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.36%
|
373,095
|
$209,780,000 | — | 30 Sep 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.36%
|
369,965
|
$208,479,691 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.33%
|
339,489
|
$190,884,479 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.31%
|
325,921
|
$183,255,598 | — | 30 Sep 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.31%
|
323,370
|
$181,676,120 | — | 30 Sep 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.3%
|
307,289
|
$172,779,386 | — | 30 Sep 2025 | |
| Swiss National Bank |
13F
|
Company |
0.29%
|
306,000
|
$172,054,620 | — | 30 Sep 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.28%
|
287,881
|
$161,866,850 | — | 30 Sep 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.27%
|
283,105
|
$159,221,740 | — | 30 Sep 2025 |
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) as of Q4 2025
As of 31 Dec 2025,
REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) was held by
1,376 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,193,388 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, Dodge & Cox, JPMORGAN CHASE & CO, FRANKLIN RESOURCES INC, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, Nuveen, LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
1,377
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
1,235
Q4 2025 holders
1,376
Holder diff
141
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.